The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Poliovirus Vaccine Inactivated-Global Market Insights and Sales Trends 2024
Synopsis
Inactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.
The global Poliovirus Vaccine Inactivated market size is expected to reach US$ 926.8 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Poliovirus Vaccine Inactivated in various end use industries. The expanding demands from the Public and Private, are propelling Poliovirus Vaccine Inactivated market. Human Diploid Cell, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monkey Kidney Cell segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Poliovirus Vaccine Inactivated, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Poliovirus Vaccine Inactivated market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Poliovirus Vaccine Inactivated market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Poliovirus Vaccine Inactivated sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Poliovirus Vaccine Inactivated covered in this report include Sanofi, GSK, Serum Institute (Bilthoven Biologicals) and IMBCA, etc.
The global Poliovirus Vaccine Inactivated market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Global Poliovirus Vaccine Inactivated market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Poliovirus Vaccine Inactivated market, Segment by Type:
Human Diploid Cell
Monkey Kidney Cell
Global Poliovirus Vaccine Inactivated market, by Application
Public
Private
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Poliovirus Vaccine Inactivated manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Poliovirus Vaccine Inactivated in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Inactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.
The global Poliovirus Vaccine Inactivated market size is expected to reach US$ 926.8 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Poliovirus Vaccine Inactivated in various end use industries. The expanding demands from the Public and Private, are propelling Poliovirus Vaccine Inactivated market. Human Diploid Cell, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monkey Kidney Cell segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Poliovirus Vaccine Inactivated, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Poliovirus Vaccine Inactivated market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Poliovirus Vaccine Inactivated market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Poliovirus Vaccine Inactivated sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Poliovirus Vaccine Inactivated covered in this report include Sanofi, GSK, Serum Institute (Bilthoven Biologicals) and IMBCA, etc.
The global Poliovirus Vaccine Inactivated market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Global Poliovirus Vaccine Inactivated market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Poliovirus Vaccine Inactivated market, Segment by Type:
Human Diploid Cell
Monkey Kidney Cell
Global Poliovirus Vaccine Inactivated market, by Application
Public
Private
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Poliovirus Vaccine Inactivated manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Poliovirus Vaccine Inactivated in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Poliovirus Vaccine Inactivated Market Overview
1.1 Poliovirus Vaccine Inactivated Product Overview
1.2 Poliovirus Vaccine Inactivated Market Segment by Type
1.2.1 Human Diploid Cell
1.2.2 Monkey Kidney Cell
1.3 Global Poliovirus Vaccine Inactivated Market Size by Type
1.3.1 Global Poliovirus Vaccine Inactivated Market Size Overview by Type (2018-2029)
1.3.2 Global Poliovirus Vaccine Inactivated Historic Market Size Review by Type (2018-2023)
1.3.3 Global Poliovirus Vaccine Inactivated Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Poliovirus Vaccine Inactivated Sales Breakdown by Type (2018-2023)
1.4.2 Europe Poliovirus Vaccine Inactivated Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Poliovirus Vaccine Inactivated Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Poliovirus Vaccine Inactivated Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Poliovirus Vaccine Inactivated Sales Breakdown by Type (2018-2023)
2 Global Poliovirus Vaccine Inactivated Market Competition by Company
2.1 Global Top Players by Poliovirus Vaccine Inactivated Sales (2018-2023)
2.2 Global Top Players by Poliovirus Vaccine Inactivated Revenue (2018-2023)
2.3 Global Top Players by Poliovirus Vaccine Inactivated Price (2018-2023)
2.4 Global Top Manufacturers Poliovirus Vaccine Inactivated Manufacturing Base Distribution, Sales Area, Product Type
2.5 Poliovirus Vaccine Inactivated Market Competitive Situation and Trends
2.5.1 Poliovirus Vaccine Inactivated Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Poliovirus Vaccine Inactivated Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poliovirus Vaccine Inactivated as of 2022)
2.7 Date of Key Manufacturers Enter into Poliovirus Vaccine Inactivated Market
2.8 Key Manufacturers Poliovirus Vaccine Inactivated Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Poliovirus Vaccine Inactivated Status and Outlook by Region
3.1 Global Poliovirus Vaccine Inactivated Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Poliovirus Vaccine Inactivated Historic Market Size by Region
3.2.1 Global Poliovirus Vaccine Inactivated Sales in Volume by Region (2018-2023)
3.2.2 Global Poliovirus Vaccine Inactivated Sales in Value by Region (2018-2023)
3.2.3 Global Poliovirus Vaccine Inactivated Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Poliovirus Vaccine Inactivated Forecasted Market Size by Region
3.3.1 Global Poliovirus Vaccine Inactivated Sales in Volume by Region (2024-2029)
3.3.2 Global Poliovirus Vaccine Inactivated Sales in Value by Region (2024-2029)
3.3.3 Global Poliovirus Vaccine Inactivated Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Poliovirus Vaccine Inactivated by Application
4.1 Poliovirus Vaccine Inactivated Market Segment by Application
4.1.1 Public
4.1.2 Private
4.2 Global Poliovirus Vaccine Inactivated Market Size by Application
4.2.1 Global Poliovirus Vaccine Inactivated Market Size Overview by Application (2018-2029)
4.2.2 Global Poliovirus Vaccine Inactivated Historic Market Size Review by Application (2018-2023)
4.2.3 Global Poliovirus Vaccine Inactivated Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Poliovirus Vaccine Inactivated Sales Breakdown by Application (2018-2023)
4.3.2 Europe Poliovirus Vaccine Inactivated Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Poliovirus Vaccine Inactivated Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Poliovirus Vaccine Inactivated Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Poliovirus Vaccine Inactivated Sales Breakdown by Application (2018-2023)
5 North America Poliovirus Vaccine Inactivated by Country
5.1 North America Poliovirus Vaccine Inactivated Historic Market Size by Country
5.1.1 North America Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Poliovirus Vaccine Inactivated Sales in Volume by Country (2018-2023)
5.1.3 North America Poliovirus Vaccine Inactivated Sales in Value by Country (2018-2023)
5.2 North America Poliovirus Vaccine Inactivated Forecasted Market Size by Country
5.2.1 North America Poliovirus Vaccine Inactivated Sales in Volume by Country (2024-2029)
5.2.2 North America Poliovirus Vaccine Inactivated Sales in Value by Country (2024-2029)
6 Europe Poliovirus Vaccine Inactivated by Country
6.1 Europe Poliovirus Vaccine Inactivated Historic Market Size by Country
6.1.1 Europe Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Poliovirus Vaccine Inactivated Sales in Volume by Country (2018-2023)
6.1.3 Europe Poliovirus Vaccine Inactivated Sales in Value by Country (2018-2023)
6.2 Europe Poliovirus Vaccine Inactivated Forecasted Market Size by Country
6.2.1 Europe Poliovirus Vaccine Inactivated Sales in Volume by Country (2024-2029)
6.2.2 Europe Poliovirus Vaccine Inactivated Sales in Value by Country (2024-2029)
7 Asia-Pacific Poliovirus Vaccine Inactivated by Region
7.1 Asia-Pacific Poliovirus Vaccine Inactivated Historic Market Size by Region
7.1.1 Asia-Pacific Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Poliovirus Vaccine Inactivated Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Poliovirus Vaccine Inactivated Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Poliovirus Vaccine Inactivated Forecasted Market Size by Region
7.2.1 Asia-Pacific Poliovirus Vaccine Inactivated Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Poliovirus Vaccine Inactivated Sales in Value by Region (2024-2029)
8 Latin America Poliovirus Vaccine Inactivated by Country
8.1 Latin America Poliovirus Vaccine Inactivated Historic Market Size by Country
8.1.1 Latin America Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Poliovirus Vaccine Inactivated Sales in Volume by Country (2018-2023)
8.1.3 Latin America Poliovirus Vaccine Inactivated Sales in Value by Country (2018-2023)
8.2 Latin America Poliovirus Vaccine Inactivated Forecasted Market Size by Country
8.2.1 Latin America Poliovirus Vaccine Inactivated Sales in Volume by Country (2024-2029)
8.2.2 Latin America Poliovirus Vaccine Inactivated Sales in Value by Country (2024-2029)
9 Middle East and Africa Poliovirus Vaccine Inactivated by Country
9.1 Middle East and Africa Poliovirus Vaccine Inactivated Historic Market Size by Country
9.1.1 Middle East and Africa Poliovirus Vaccine Inactivated Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Poliovirus Vaccine Inactivated Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Poliovirus Vaccine Inactivated Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Poliovirus Vaccine Inactivated Forecasted Market Size by Country
9.2.1 Middle East and Africa Poliovirus Vaccine Inactivated Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Poliovirus Vaccine Inactivated Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Poliovirus Vaccine Inactivated Products Offered
10.1.5 Sanofi Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Poliovirus Vaccine Inactivated Products Offered
10.2.5 GSK Recent Development
10.3 Serum Institute (Bilthoven Biologicals)
10.3.1 Serum Institute (Bilthoven Biologicals) Company Information
10.3.2 Serum Institute (Bilthoven Biologicals) Introduction and Business Overview
10.3.3 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Products Offered
10.3.5 Serum Institute (Bilthoven Biologicals) Recent Development
10.4 IMBCA
10.4.1 IMBCA Company Information
10.4.2 IMBCA Introduction and Business Overview
10.4.3 IMBCA Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2018-2023)
10.4.4 IMBCA Poliovirus Vaccine Inactivated Products Offered
10.4.5 IMBCA Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Poliovirus Vaccine Inactivated Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Poliovirus Vaccine Inactivated Industrial Chain Analysis
11.4 Poliovirus Vaccine Inactivated Market Dynamics
11.4.1 Poliovirus Vaccine Inactivated Industry Trends
11.4.2 Poliovirus Vaccine Inactivated Market Drivers
11.4.3 Poliovirus Vaccine Inactivated Market Challenges
11.4.4 Poliovirus Vaccine Inactivated Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Poliovirus Vaccine Inactivated Distributors
12.3 Poliovirus Vaccine Inactivated Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
